This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Value vs. Growth: 3 Stocks Investors Should Buy for Each Style
by Ethan Feller
Growth leads value so far this year, but will it continue...
Sabre (SABR) to Upgrade Kempinski's Client Booking Experience
by Zacks Equity Research
Under the newly signed technology agreement, Sabre (SABR) is likely to help Europe's oldest luxury hotel chain operator, Kempinski Hotels, upgrade its customers' booking experience.
5 Top Stocks Likely to Come Up With Earnings Beat
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their next releases. Tap Ulta Beauty (ULTA), Hologic (HOLX), Fortinet (FTNT), Splunk (SPLK) and ServiceNow (NOW).
Is Lattice Semiconductor (LSCC) Outperforming Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Here is how Lattice Semiconductor (LSCC) and ServiceNow (NOW) have performed compared to their sector so far this year.
Sabre (SABR) to Offer SynXis Solution to Tian Xia Fang Cang
by Zacks Equity Research
Sabre (SABR) enters into an agreement with Tian Xia Fang Cang to provide its Hospitality solutions to create new opportunities for post-pandemic recovery and revenue growth in Chinese hotels.
NVIDIA's (NVDA) Q4 Earnings to be Hurt by Weak Chip Demand
by Zacks Equity Research
NVIDIA's (NVDA) overall financial performance in the fourth quarter of fiscal 2023 is likely to have been hurt by the weakening demand for chips used in the gaming end market.
Wall Street Analysts See ServiceNow (NOW) as a Buy: Should You Invest?
by Zacks Equity Research
The average brokerage recommendation (ABR) for ServiceNow (NOW) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Twilio (TWLO) Jumps 12% on Q4 Earnings Beat, Strong Guidance
by Zacks Equity Research
Twilio's (TWLO) Q4 performance reflects the benefits of the constant expansion of its international business and the continuous acceleration of digital transformation projects across several industries.
Sabre (SABR) Plunges 19% on Wider-Than-Expected Q4 Loss
by Zacks Equity Research
Sabre's (SABR) lower-than-expected Q4 top-line performance raises concerns for the slow post-pandemic recovery of the travel technology company.
Sabre (SABR) Renews Multi-Year Deal With JetBlue Airways
by Zacks Equity Research
The latest renewed multi-year agreement with JetBlue Airways depicts the growing trust in Sabre's (SABR) PSS and GDS solutions by leading air carriers.
CyberArk (CYBR) Q4 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
CyberArk's (CYBR) fourth-quarter 2022 results reflect the strong demand for the company's SaaS solutions and on-premise subscription offerings.
The Zacks Analyst Blog Highlights Salesforce, ServiceNow, Okta, Unity Software and Splunk
by Zacks Equity Research
Salesforce, ServiceNow, Okta, Unity Software and Splunk are included in this Analyst Blog.
CDW vs. NOW: Which Stock Is the Better Value Option?
by Zacks Equity Research
CDW vs. NOW: Which Stock Is the Better Value Option?
How to Boost Your Portfolio with Top Computer and Technology Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
5 Tech Stocks to Buy on the Dip to Gain From Sector Churn
by Nalak Das
We have narrowed our search to five large-cap U.S.-based technology stocks with attractive valuations. These are: U, SPLK, OKTA, CRM and NOW
Zacks.com featured highlights Genmab, Hologic, ServiceNow and Splunk
by Zacks Equity Research
Genmab, Hologic, ServiceNow and Splunk have been highlighted in this Screen of The Week article.
4 Top Stocks to Buy on Earnings Beat Potential
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their next releases. These stocks include Genmab (GMAB), Hologic (HOLX), ServiceNow (NOW) and Splunk (SPLK).
Paycom (PAYC) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Paycom's (PAYC) Q4 results reflect the benefits of strong demand, new business wins and the adoption of recent new product offerings.
NCR Corporation (NCR) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
NCR Corporation's (NCR) Q4 results reflect strong execution, solid growth across business segments, increased pricing and cost-saving actions.
Fortinet (FTNT) Soars 13% on Q4 Earnings Beat, Strong Guidance
by Zacks Equity Research
The strong demand for Core and Enhanced Platform Technologies aids Fortinet's (FTNT) Q4 top line, while an improved supply chain, positive pricing actions and discounting policies in the Product segment drive earnings higher.
Gen Digital (GEN) Tops on Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Gen Digital's (GEN) Q3 results reflect strong customer growth and the benefits of the global business expansion and the Avast acquisition, leading to year-over-year growth in revenues and bookings.
Paylocity (PCTY) Soars 4% on Q2 Earnings Beat, Guidance Raise
by Zacks Equity Research
Better sales execution and sustained investments in technological upgrades and product innovation drive Paylocity's (PCTY) Q2 earnings and revenues higher.
DXC Technology (DXC) Q3 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
DXC Technology's (DXC) Q3 earnings rise year over year, primarily driven by lower interest expenses and a reduction in share counts, partially offset by lower sales volumes and foreign exchange headwinds.
Should You Invest in ServiceNow (NOW) Based on Bullish Wall Street Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in ServiceNow (NOW). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Amdocs (DOX) Earnings and Revenues Beat Estimates in Q1
by Zacks Equity Research
Continued strength in North America and healthy activity levels in Europe drive Amdocs' (DOX) Q1 revenues higher, while the lower effective tax rate and an improved operating margin aid non-GAAP earnings.